Industry leaders to discuss the future of healthcare at World HealthEx Forum 2017

Thu, 12/10/2017 - 16:15

London, UK, 12th October 2017 / Sciad NewswireIndustry leaders will discuss the future of healthcare at Biotech and Money’s World HealthEx Forum on 13th November 2017. The inaugural event brings together board-level executives from across the life science sector who are involved in shaping the future of health.​

Sir Richard Sykes, Chairman of the NHS Trust, will present the opening keynote address, where he will discuss the impact of disruptive healthcare technologies and services, and outline the NHS’ vision for the future of patient care.​

Participants will also learn about the developments set to shape the life science landscape from regulatory, investor, and pharma perspectives. Sir Andrew Dillon, Chief Executive Officer at NICE, will examine how concepts of value differ between payers, pharma and biotech, and provide insights on how value can be evaluated and measured. Hubert Birner, Managing Partner at TVM Capital, will explore how investment in healthcare is evolving, while Jane Griffiths, Global Head at Actelion, will discuss how the industry can ensure it is encouraging innovation and enabling better outcomes for patients.  ​

The event will include eight sub-sector forums, where senior executives will share case studies, experiences, and best practice under the Chatham House Rule. The forums are designed to provide strategic insights and actionable outcomes, while generating high-level debate about the key issues facing the sector. The forums will take a deep-dive approach by connecting peers within eight future-focused healthcare sub-sectors, including: cell and gene therapy; digital health; immuno-oncology; medtech and medical devices; neuroscience and the central nervous system; precision medicine; life science investment; pharma global business development.​

The World HealthEx Forum 2017 will take place at etc.venues, 200 Aldersgate, London. It will be followed by Biotech and Money’s Inv€$tival Showcase on 14th November, in exclusive partnership with Jefferies LLC. This will see the life science and investment community convene at the Waldorf Hilton, London, for a corporate showcase of the latest innovative life science and healthcare investment and partnering opportunities, leading into the Jefferies Global Healthcare Conference on 15th-16th November.​

Over the course of the World HealthEx Forum and Inv€$tival Showcase, attendees can take advantage of a one-to-one partnering tool and a range of networking opportunities.

Sir Richard Sykes, Chairman of the NHS Trust, said: “I fully endorse the bold mission of the World HealthEx Forum to be a powerful vehicle for new ideas and actionable outcomes. This unique forum of leaders will help enable the healthcare sector to meet the significant challenges it faces in the years ahead. I look forward to opening the Forum and addressing you in London in November, where, together, we can work towards delivering a more efficient and prosperous healthcare ecosystem and bring improved treatments and cures for the benefit of patients.”​

Neil Darkes, Co-CEO at Biotech and Money, added: “We’ve positioned the World HealthEx Forum to emulate the outcome-orientated nature of the World Economic Forum, but to specifically focus on the life science sector. We’re delighted to be providing the platform for executives, KOLs and industry stakeholders to come together to discuss and shape the future of their sector. We see this as the ‘Davos’ of life sciences.”​


For further information, please contact:

Josh Dance
Senior Vice President at Biotech and Money
T: +44 (0) 203 637 5908 ext. 2
M: +44 (0)7445 519 689

Notes to Editors

About Biotech and Money
Biotech and Money is an influential community of senior life science decision makers. We are a catalyst for dialogue, debate and deal making to help lead growth in healthcare investment and the building of billion-dollar healthcare business. We are determined to forge a fundamentally better way to promote and facilitate investment, financing, partnerships, and deal making in healthcare.

Find out more about the World HealthEx Forum at